Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
Add the expiry date on your pack for a full Trust Score.
Enspryng Solution for Injection contains Satralizumab (120 mg/1 mL), as solution for injection, according to its NAFDAC registration record.
Yes. Enspryng Solution for Injection is listed on the NAFDAC register under registration number A6-100128, and its registration is active as of 28 October 2026.
No WHO falsified or substandard medical product alert currently matches Enspryng Solution for Injection in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A6-100128, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.